Hannan Katherine M, Brandenburger Yves, Jenkins Anna, Sharkey Kerith, Cavanaugh Alice, Rothblum Lawrence, Moss Tom, Poortinga Gretchen, McArthur Grant A, Pearson Richard B, Hannan Ross D
Trescowthick Research Laboratories, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, USA.
Mol Cell Biol. 2003 Dec;23(23):8862-77. doi: 10.1128/MCB.23.23.8862-8877.2003.
Mammalian target of rapamycin (mTOR) is a key regulator of cell growth acting via two independent targets, ribosomal protein S6 kinase 1 (S6K1) and 4EBP1. While each is known to regulate translational efficiency, the mechanism by which they control cell growth remains unclear. In addition to increased initiation of translation, the accelerated synthesis and accumulation of ribosomes are fundamental for efficient cell growth and proliferation. Using the mTOR inhibitor rapamycin, we show that mTOR is required for the rapid and sustained serum-induced activation of 45S ribosomal gene transcription (rDNA transcription), a major rate-limiting step in ribosome biogenesis and cellular growth. Expression of a constitutively active, rapamycin-insensitive mutant of S6K1 stimulated rDNA transcription in the absence of serum and rescued rapamycin repression of rDNA transcription. Moreover, overexpression of a dominant-negative S6K1 mutant repressed transcription in exponentially growing NIH 3T3 cells. Rapamycin treatment led to a rapid dephosphorylation of the carboxy-terminal activation domain of the rDNA transcription factor, UBF, which significantly reduced its ability to associate with the basal rDNA transcription factor SL-1. Rapamycin-mediated repression of rDNA transcription was rescued by purified recombinant phosphorylated UBF and endogenous UBF from exponentially growing NIH 3T3 cells but not by hypophosphorylated UBF from cells treated with rapamycin or dephosphorylated recombinant UBF. Thus, mTOR plays a critical role in the regulation of ribosome biogenesis via a mechanism that requires S6K1 activation and phosphorylation of UBF.
雷帕霉素的哺乳动物靶点(mTOR)是细胞生长的关键调节因子,通过两个独立靶点发挥作用,即核糖体蛋白S6激酶1(S6K1)和4EBP1。虽然已知它们各自调节翻译效率,但其控制细胞生长的机制仍不清楚。除了增加翻译起始外,核糖体的加速合成和积累是高效细胞生长和增殖的基础。使用mTOR抑制剂雷帕霉素,我们发现mTOR是血清诱导的45S核糖体基因转录(rDNA转录)快速持续激活所必需的,rDNA转录是核糖体生物合成和细胞生长中的一个主要限速步骤。在无血清条件下,组成型活性、雷帕霉素不敏感的S6K1突变体的表达刺激了rDNA转录,并挽救了雷帕霉素对rDNA转录的抑制。此外,显性负性S6K1突变体的过表达抑制了指数生长的NIH 3T3细胞中的转录。雷帕霉素处理导致rDNA转录因子UBF的羧基末端激活结构域快速去磷酸化,这显著降低了其与基础rDNA转录因子SL-1结合的能力。从指数生长的NIH 3T3细胞中纯化的重组磷酸化UBF和内源性UBF挽救了雷帕霉素介导的rDNA转录抑制,但用雷帕霉素处理的细胞中的低磷酸化UBF或去磷酸化的重组UBF则不能。因此mTOR通过一种需要S6K1激活和UBF磷酸化的机制在核糖体生物合成的调节中起关键作用。